The immune system abnormalities of scleroderma are diverse and in asso
ciation with vascular and mesenchymal cell abnormalities, contribute t
o the organ system dysfunction and clinical expression of the disease.
Recent insights into novel immune regulatory pathways, immune reactiv
ity to self-antigens, and the potential association of persistent feta
l cells and disease expression may serve to increase our understanding
of this enigmatic disease. Copyright (C) 1998 by W.B. Saunders Compan
y.